Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fath, R. Auch Kinder ab sechs Jahren profitieren nun von Dupilumab. Pädiatrie 34, 52–53 (2022). https://doi.org/10.1007/s15014-022-4089-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15014-022-4089-y